See more : Spenta International Limited (SPENTA.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Perimeter Medical Imaging AI, Inc. (PYNKF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Perimeter Medical Imaging AI, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Startech Labs, Inc. (LAAB) Income Statement Analysis – Financial Results
- Mobotix AG (MBQ.DE) Income Statement Analysis – Financial Results
- Aichi Corporation (6345.T) Income Statement Analysis – Financial Results
- Jiangsu Maysta Chemical Co., Ltd. (603041.SS) Income Statement Analysis – Financial Results
- Drax Group plc (DRXGF) Income Statement Analysis – Financial Results
Perimeter Medical Imaging AI, Inc. (PYNKF)
About Perimeter Medical Imaging AI, Inc.
Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT, B-series OCT, and OCT imaging console. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. was founded in 2013 and is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 403.53K | 132.77K | 11.34K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 197.11K | 32.14K | 6.30K | 47.57K | 51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 206.42K | 100.63K | 5.04K | -47.57K | -51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 51.15% | 75.79% | 44.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 6.83M | 5.48M | 4.50M | 468.31K | 643.35K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.12M | 5.45M | 7.89M | 8.84M | 7.51M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 4.96M | 4.84M | 3.67M | 122.94K | 36.78K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 14.68M | 10.28M | 11.56M | 8.96M | 7.54M | 135.62K | 123.44K | 137.17K | 184.42K |
| Other Expenses | 0.00 | 463.68K | 3.57K | 629.17K | 376.57K | 20.42K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 21.51M | 16.22M | 16.06M | 10.06M | 8.56M | 115.20K | 123.44K | 137.17K | 184.42K |
| Cost & Expenses | 21.58M | 16.25M | 16.07M | 10.06M | 8.56M | 115.20K | 123.44K | 137.17K | 184.42K |
| Interest Income | 0.00 | 0.00 | 10.36K | 6.90K | 4.65K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 104.93K | 110.31K | 117.05K | 155.97K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 614.70K | 1.04M | 93.84K | 47.57K | 51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -13.28M | -11.72M | -15.95M | -6.11M | -7.01M | -115.20K | -123.44K | -137.17K | -184.42K |
| EBITDA Ratio | -3,290.15% | -11,539.44% | -140,655.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -20.73M | -16.12M | -16.05M | -11.67M | -13.02M | -115.20K | -123.44K | -137.17K | -184.42K |
| Operating Income Ratio | -5,137.06% | -12,142.65% | -141,482.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.79M | 6.22M | -3.86M | 2.13M | -2.22M | 820.86K | 1.70M | -4.70M | -107.31K |
| Income Before Tax | -18.94M | -9.91M | -16.65M | -7.89M | -10.34M | 705.67K | 1.58M | -4.83M | -291.73K |
| Income Before Tax Ratio | -4,694.58% | -7,461.33% | -146,802.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 2.00 | -6.32M | 110.31K | 117.05K | 155.97K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -18.94M | -3.59M | -16.76M | -8.00M | -10.50M | 705.67K | 1.58M | -4.83M | -291.73K |
| Net Income Ratio | -4,694.58% | -2,700.97% | -147,774.66% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.29 | -0.06 | -0.38 | -0.29 | -0.82 | 0.05 | 0.12 | -0.36 | -0.02 |
| EPS Diluted | -0.29 | -0.06 | -0.38 | -0.29 | -0.82 | 0.05 | 0.12 | -0.36 | -0.02 |
| Weighted Avg Shares Out | 64.67M | 60.62M | 44.11M | 27.22M | 12.82M | 13.30M | 13.30M | 13.30M | 13.30M |
| Weighted Avg Shares Out (Dil) | 64.67M | 60.62M | 44.11M | 27.22M | 12.82M | 13.30M | 13.30M | 13.30M | 13.30M |
Perimeter Medical Imaging AI advances to next stage of grant funding program
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) announced that it has been shortlisted in a grant funding process sponsored by the Advanced Research Projects Agency for Health (ARPA-H) as part of its Precision Surgical Interventions (PSI) program. In alignment with the...
Perimeter Medical Imaging AI Shortlisted to Advance to Next Stage of Grant Funding Program Sponsored by the Advanced Research Projects Agency for Health (ARPA-H) under Biden Cancer Moonshot Initiative
New Precision Surgical Interventions (PSI) Program Aims to Fund the Development of Groundbreaking New Tools for Cancer Surgeons DALLAS and TORONTO , Oct. 5, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") –...
Perimeter Medical Imaging AI Announces Issuance and Amendment of Options
TORONTO and DALLAS , Sept. 13, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that, on September 13, 2023, it granted 3,523,408 stock options to...
Perimeter Medical Imaging AI adds experienced MedTech sales exec to leadership team
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) has appointed experienced MedTech sales executive Adam Hodges as its vice president of sales and marketing. The company said that he brings more than 20 years of commercialization experience in the medical device industry,...
Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing
TORONTO and DALLAS , Sept. 8, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced the appointment of experienced medtech sales executive, Adam Hodges, as its...
Perimeter Medical Imaging AI announces FDA alignment on key elements of ongoing B-Series OCT trial
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) told investors that feedback from the US Foods and Drug Administration shows alignment on key elements of its ongoing clinical trial evaluating the use of its B-Series OCT combined with its proprietary ImgAssist AI...
Perimeter Medical Imaging AI Announces Alignment with FDA on Key Elements of Ongoing Clinical Trial Evaluating AI-enabled B-Series OCT Medical Imaging Technology
Enhanced Artificial Intelligence Software and Interim Analysis Integrated into Current Study TORONTO and DALLAS , Sept. 7, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today provided...
Perimeter Medical Imaging AI, Inc. (PYNKF) Q2 2023 Earnings Call Transcript
Perimeter Medical Imaging AI, Inc. (OTCPK:PYNKF) Q2 2023 Earnings Conference Call August 29, 2023 5:00 PM ET Company Participants Jodi Regts - Investor Relations Adrian Mendes - Chief Executive Officer Andrew Berkeley - Co-Founder Conference Call Participants Scott McAuley -...
Perimeter Medical Imaging AI ends 2Q with $20.9M in cash for "next generation" AI innovations
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) ended its second quarter with a cash balance of nearly $20.9 million for new CEO Adrian Mendes to execute its clinical development program. The Toronto- and Dallas-based firm received approval from the US FDA...
Perimeter Medical Imaging AI Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Conference Call/Webcast Today at 5 pm ET TORONTO and DALLAS , Aug. 29, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for...
Source: https://incomestatements.info
Category: Stock Reports